10.1186/s12974-017-0839-0 12 CaoM.MuX.JiangC.YangG.ChenH.XueW
[DOI] [PubMed] [Google Scholar] 65.Ruseva A, Wojcich M, Fabbricatore A, Hartaigh BO, Wang BJ, Zhao Z1733-P: Two-year real-world effectiveness of semaglutide in patients with obesity or overweight
GLP-1 and Satiety In the pursuit of effective weight management, GLP-1 and satiety are gaining attention
Heavy alcohol use may be a pancreatitis trigger
Novo Nordisk, the parent company of Wegovy, told Newsweek that this study "highlights the chronic nature of obesity and suggest that ongoing treatment is necessary." Eli Lilly and Company, the parent company of Mounjaro, told Newsweek : "When treatment is stopped, weight can return, which reflects the biology of the condition rather than a lack of effort." Newsweek reached out to the Centers for Disease Control and Prevention (CDC) via email for comment